UAE, March 6 -- The global incidence rate of Inflammatory Bowel Disease (IBD) has been increasing from 1990 to 2021 as per the figures provided by the Global Burden of Disease Organization with a rising trend in Asian countries that requires immediate attention. Thanks to the awareness created globally there is now early detection methods, improved management, and new treatments to alleviate the condition. At a conference (IBD Nexus) organized by Takeda, a global biopharmaceutical leader, committed to advancing patient care, and one of the stakeholders in the Inflammatory Bowel Disease (IBD) therapeutic area, many healthcare professionals and gastroenterologists from around the world conferred about the epidemiology, symptoms and new age tr...